Pages that link to "Q37068893"
Jump to navigation
Jump to search
The following pages link to Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene (Q37068893):
Displaying 30 items.
- The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical Diseases (Q26797488) (← links)
- Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine (Q27334697) (← links)
- Novel vaccines to human rabies (Q33507253) (← links)
- Characterization of a single-cycle rabies virus-based vaccine vector (Q33676502) (← links)
- Investigating the role for IL-21 in rabies virus vaccine-induced immunity (Q34630598) (← links)
- Lymph node but not intradermal injection site macrophages are critical for germinal center formation and antibody responses to rabies vaccination (Q35076738) (← links)
- Immunogenicity studies in carnivores using a rabies virus construct with a site-directed deletion in the phosphoprotein (Q35224835) (← links)
- Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses (Q35275167) (← links)
- Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. (Q36073443) (← links)
- A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses (Q36294739) (← links)
- Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection (Q36363223) (← links)
- Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein. (Q37006752) (← links)
- Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression (Q37069798) (← links)
- Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements (Q37099853) (← links)
- B cell infection and activation by rabies virus-based vaccines (Q37123384) (← links)
- Reinvestigating the role of IgM in rabies virus postexposure vaccination (Q37123389) (← links)
- ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo (Q37529574) (← links)
- A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge. (Q37548524) (← links)
- The cell biology of rabies virus: using stealth to reach the brain (Q37641016) (← links)
- Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs (Q37664892) (← links)
- Experimental rabies vaccines for humans (Q37798009) (← links)
- Rabies virus as a research tool and viral vaccine vector (Q37877958) (← links)
- Rabies vaccine development by expression of recombinant viral glycoprotein (Q38735052) (← links)
- Development of recombinant rabies viruses vectors with Gaussia luciferase reporter based on Chinese vaccine strain CTN181 (Q39529861) (← links)
- APRIL:TACI axis is dispensable for the immune response to rabies vaccination (Q40158110) (← links)
- Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis (Q40355293) (← links)
- T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue (Q40980505) (← links)
- Localization of rabies virus glycoprotein into the endoplasmic reticulum produces immunoprotective antigen. (Q45357593) (← links)
- Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge. (Q52586088) (← links)
- Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy (Q83781807) (← links)